Stock Market & Financial Investment News

News Breaks December 13, 2012 06:22 EDT SNTA Synta Pharmaceuticals initiated with a Buy at Brean Capital Target $12. News For SNTA From The Last 14 Days Check below for free stories on SNTA the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 10, 2013 12:32 EDT SNTA Options with increasing implied volatility: SNTA BKS FIO QIHU VMED May 8, 2013 08:00 EDT SNTA Synta downgraded to Market Perform from Outperform at BMO Capital Subscribe for More Information May 7, 2013 12:16 EDT SNTA Synta downgraded to Market Perform from Outperform at BMO Capital BMO Capital downgraded Synta Pharmaceuticals citing uncertainty followinig the resignation of Dr. Ramachandra. May 6, 2013 17:58 EDT SNTA Synta Pharmaceuticals R&D president Ramachandra resigns Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.